GE HealthCare has delivered the initial subject doses of a positron emission tomography (PET) myocardial perfusion imaging ...
Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...
Early detection of Alzheimer’s disease (AD) can improve treatment outcomes, but current testing methods still have ...
Positron Corporation (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical support services, is pleased to announce it has entered ...
GE HealthCare (GEHC) has delivered the first patient doses of Flyrcado or flurpiridaz F 18 njection, a first-of-its-kind unit dose positron ...
News Medical on MSN7d
Neurofilament light as a translational biomarker from preclinical drug discovery to clinical applicationNeurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.
A discovery of how to target mutated proteins in tumors made a decade ago never matured into a surefire way of destroying ...
Nuclear cardiology is a specialised field in nuclear medicine that evaluates the heart function to help diagnosing conditions ...
8d
News Medical on MSNBlood test for Alzheimer’s could replace costly and invasive spinal tapsResearchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing ...
Market Growth Is Driven by Technological Innovations and An Increasing Incidence of Chronic Diseases.Pune, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Global Positron Emission Tomography Market Size & Growth ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results